GlaxoSmithKline PLC (GSK) Social Stream
Glaxosmithkline Plc (GSK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Glaxosmithkline Plc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 19 | $60.58 | $33.51 | $46.02 | $39.22 | 17.34% |
The Trend in the Analyst Price Target
Over the past 143 days, GSK's average price target has gone down $1.64.
Over the past 177 days, GSK's average upside potential has been 25.94%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-29 | 19 | 60.58 | 33.51 | 46.02 | 37.07 | 24.14% |
| 2020-11-28 | 19 | 60.58 | 33.51 | 46.02 | 37.07 | 24.14% |
| 2020-11-19 | 19 | 60.58 | 33.51 | 45.97 | 37.14 | 23.77% |
| 2020-11-13 | 19 | 60.58 | 33.51 | 45.85 | 38.30 | 19.71% |
| 2020-10-29 | 18 | 60.58 | 33.51 | 46.09 | 33.96 | 35.72% |
| 2020-10-02 | 18 | 60.41 | 40.14 | 47.99 | 37.24 | 28.87% |
| 2020-09-23 | 17 | 60.41 | 40.14 | 48.39 | 37.79 | 28.05% |
| 2020-09-17 | 17 | 60.41 | 40.14 | 48.61 | 39.47 | 23.16% |
| 2020-09-03 | 16 | 57.04 | 38.62 | 47.88 | NA | NA% |
| 2020-08-28 | 16 | 57.04 | 38.62 | 47.75 | NA | NA% |
| 2020-08-19 | 16 | 57.04 | 38.62 | 47.79 | NA | NA% |
| 2020-08-12 | 17 | 57.04 | 38.62 | 48.20 | NA | NA% |
| 2020-08-05 | 17 | 57.04 | 38.62 | 48.27 | NA | NA% |
| 2020-07-25 | 17 | 56.08 | 39.21 | 47.99 | NA | NA% |
| 2020-07-16 | 17 | 55.35 | 39.11 | 47.75 | NA | NA% |
| 2020-07-09 | 17 | 55.35 | 39.11 | 47.66 | NA | NA% |
| 2020-07-04 | 17 | 55.35 | 38.64 | 47.40 | NA | NA% |
| 2020-06-25 | 18 | 55.35 | 38.46 | 47.28 | NA | NA% |
| 2020-06-18 | 18 | 55.35 | 38.49 | 47.15 | NA | NA% |
| 2020-06-11 | 18 | 55.35 | 39.19 | 47.15 | NA | NA% |
| 2020-06-05 | 18 | 55.35 | 39.08 | 47.15 | NA | NA% |
GSK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
GSK's average broker recommendation rating improved by 0.58 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The number of analysts covering the stock of GSK is higher than 92.04% of all US stocks.
- Glaxosmithkline Plc's variance in analysts' estimates is lower than 17.83% of all US stocks.
- Glaxosmithkline Plc's upside potential (average analyst target price relative to current price) is higher than 13.15% of Pharmaceutical Products stocks.
- Glaxosmithkline Plc's average analyst price target is greater than 76.22% of Pharmaceutical Products stocks.
Make investment decisions regarding GSK using the data that counts. Try POWR Ratings for free.